Back to results
US 11,453,711 B2Granted
Fusion proteins of GLP-1 and GDF15 and conjugates thereof
AssigneeBeijing Ql Biopharmaceutical Co., Ltd.
InventorsYuanyuan Zhang, Haixia Zou, Xinyu Zhao, Yaoguang Jin, Xu Chen, Peng Zhai, Wei Guo
Life of this patent
Estimating the term…
Abstract
The present disclosure provides fusion polypeptides comprising GLP-1 and GDF15, the polypeptide complexes, and the conjugates thereof. Pharmaceutical compositions comprising the same and methods of treating diseases are also provided.
Claims26
A fusion polypeptide comprising, from N terminus to C terminus, GLP-1, a polypeptide linker and GDF15, wherein the polypeptide linker has a length of at least 80 amino acid residues;
- wherein the GLP-1 comprises the amino acid sequence of X7X8EGTFTSDVSSYLEX22QAAX26X27FIAWLVX34GX36G (SEQ ID NO:
- 325), wherein:
- the X7 is H;
- the X8 is A, G, S, V, or Aib;
- the X22 is G, or E;
- the X26 is K, or R;
- the X27 is E;
- the X34 is R, or K, and the X36 is K, R, or G;
- and
- wherein the GDF15 comprises a combination of substitutions selected from the group consisting of:
- 1) N3Q, M57L, K69R, K107R, and K91R;
- 2) N3Q, K69R, K107R, and K91R;
- 3) K69R, K107R, and K91R;
- 4) N3Q, M57L, K107R, and K91R;
- 5) N3Q, K107R, and K91R;
- 6) K107R, and K91R;
- 7) N3Q, M57L, K69R, and K91R;
- 8) Deletion of the first three amino acid residues from the N-terminus of GDF-15 and M57L;
- 9) N3Q, M57L, M86L, K69R, K107R, K91R;
- 10) N3Q, M57L;
- 11) M57L;
- and 12) M57L, K69R, K107R, K91R, relative to the amino acid sequence of SEQ ID NO:
- 248,
- wherein the fusion polypeptide comprises only one conjugatable residue, in which the conjugatable residue is present in the polypeptide linker;
- wherein the conjugatable residue is introduced to a position ranging from the 5th to the 51st residues in the amino acid sequence of the polypeptide linker, with the N terminal residue in the polypeptide linker being the 1st residue.
22 more elements
Dependencies are inferred from the claim text.